Literature DB >> 16998148

Trans fatty acids and coronary heart disease.

Gary P Zaloga1, Kevin A Harvey, William Stillwell, Rafat Siddiqui.   

Abstract

Epidemiologic evidence has linked trans fatty acids (TFAs) in the diet to coronary heart disease in human populations. It has been estimated that dietary TFAs from partially hydrogenated oils may be responsible for between 30,000 and 100,000 premature coronary deaths per year in the United States. Although it is known that TFAs increase low-density lipoprotein (LDL) cholesterol levels and decrease high-density lipoprotein (HDL) cholesterol levels (markers of coronary heart disease), there is little known about the mechanisms by which TFAs actually function at the cellular level. It is unknown what levels of TFAs are clinically significant and it is unclear how TFAs are associated with cardiac arrhythmias or sudden cardiac death. We hypothesize that TFAs affect membrane structure, thus altering enzymatic pathways that may subsequently induce cardiac arrhythmias and sudden death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998148     DOI: 10.1177/0115426506021005505

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  13 in total

1.  Replacements for trans fats-will there be an oil shortage?

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2007-05

2.  Combinations of mutant FAD2 and FAD3 genes to produce high oleic acid and low linolenic acid soybean oil.

Authors:  Anh-Tung Pham; J Grover Shannon; Kristin D Bilyeu
Journal:  Theor Appl Genet       Date:  2012-04-04       Impact factor: 5.699

Review 3.  Perspective: interesterified triglycerides, the recent increase in deaths from heart disease, and elevated blood viscosity.

Authors:  Gregory D Sloop; Joseph J Weidman; John A St Cyr
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01

4.  Associations between trans fatty acid consumption and colon cancer among Whites and African Americans in the North Carolina colon cancer study I.

Authors:  Lisa C Vinikoor; Jessie A Satia; Jane C Schroeder; Robert C Millikan; Christopher F Martin; Joseph G Ibrahim; Robert S Sandler
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

5.  Consumption of trans-fatty acid and its association with colorectal adenomas.

Authors:  Lisa C Vinikoor; Jane C Schroeder; Robert C Millikan; Jessie A Satia; Christopher F Martin; Joseph Ibrahim; Joseph A Galanko; Robert S Sandler
Journal:  Am J Epidemiol       Date:  2008-06-27       Impact factor: 4.897

6.  trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II.

Authors:  Lisa C Vinikoor; Robert C Millikan; Jessie A Satia; Jane C Schroeder; Christopher F Martin; Joseph G Ibrahim; Robert S Sandler
Journal:  Cancer Causes Control       Date:  2009-10-20       Impact factor: 2.506

7.  Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts.

Authors:  Sanjay Misra; Alex A Fu; Alessandra Puggioni; Kamran M Karimi; Jaywant N Mandrekar; James F Glockner; Luis A Juncos; Bilal Anwer; Antonio M McGuire; Debabrata Mukhopadhyay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-07       Impact factor: 4.733

8.  TALEN-mediated targeted mutagenesis of fatty acid desaturase 2 (FAD2) in peanut (Arachis hypogaea L.) promotes the accumulation of oleic acid.

Authors:  Shijie Wen; Hao Liu; Xingyu Li; Xiaoping Chen; Yanbin Hong; Haifen Li; Qing Lu; Xuanqiang Liang
Journal:  Plant Mol Biol       Date:  2018-04-26       Impact factor: 4.076

9.  Association of rs2072183 SNP and serum lipid levels in the Mulao and Han populations.

Authors:  Lin Miao; Rui-Xing Yin; Xi-Jiang Hu; Dong-Feng Wu; Xiao-Li Cao; Qing Li; Ting-Ting Yan; Lynn Htet Htet Aung; Jin-Zhen Wu; Wei-Xiong Lin
Journal:  Lipids Health Dis       Date:  2012-05-30       Impact factor: 3.876

10.  Biophytum sensitivum: Ancient medicine, modern targets.

Authors:  K M Sakthivel; C Guruvayoorappan
Journal:  J Adv Pharm Technol Res       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.